Yes! Mantoo, This was Expected and predicted in 118.4, Today is the 5th Working day. Today also Many Cheque clearances would be reaching to ESCROW account.
Tomorrow also evening may not be possible, I Expect only in the late night.
Subscribe for listing gains… Sharda Cropchem (Sharda) is a crop protection chemical company engaged in the marketing and distribution of a wide range of formulations and generic active ingredients globally. It is also involved in order based procurement and supply of belts, general chemicals, dyes and dye intermediates. The topline and bottomline have grown at a CAGR of 22.1% and 38.6%, respectively, in FY10-14. In FY14, the company clocked a consolidated topline of | 782 crore with ~82.5% being contributed by the agro chemical business (| 645 crore), ~15.8% being contributed by the conveyor belt business (| 123 crore) and ~1.7% being contributed by other business (dyes). The company is export-oriented and realises a healthy 97% of its topline from exports. Among geographies, it has major exposure to the European Union, which constitutes ~61.3% of its FY14 consolidated revenue. Investment Rationale High number of registrations- key USP Sharda has an asset-light business model whereby it focuses on identifying generic molecules, preparing dossiers, seeking registrations, marketing and distributing formulations through third-party distributors or its own sales force. The company as of FY14 holds around 1200 registrations of which the European Union constitutes ~45% (534 registrations), Latin America ~26% (312 registrations), Nafta ~6% while the rest of world (RoW) comprises the remaining ~23%. Aslight model healthy balance sheet coupled with good return ratios By virtue of following an aslight model, Sharda has a healthy balance sheet with debt-equity at 0.1x FY14. As of FY14, the company holds ~| 197 crore of fixed assets comprising | 62 crore of intangible assets (registrations) and | 134 crore of intangible assets under development (registrations in various stages of development). The company has a net cash of | 151 crore as of FY14. Sharda also commands healthy return ratios with RoE and RoCE of 20.9% and 21.1%, respectively, in FY14. Concerns • Stretched working capital cycle (~90+ days) • Company’s trademark not registered • Growth of GM crops limiting growth of agro chemicals Available at 13.2x FY14 P/E & 2.5x FY14 P/BV recommend SUBSCRIBE At the upper price band of | 156, the company is available at a P/E of 13.2x on FY14 EPS. We reiterate that this issue is essentially an offer for sale wherein no proceeds from the issue will be ploughed back in the company. We recommend SUBSCRIBE on the issue for listing gains. From ICICI Direct